New Results

Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in precision-medicine oriented early phase clinical trials

Pedro Torres-Ayuso, Sudhakar Sahoo, Melanie Galvin, Hui Sun Leong, Kristopher K Frese, Andrew Hughes, Richard Marais, Caroline Dive, Matthew G Krebs, John Brognard
doi: https://doi.org/10.1101/254342

Article usage

Article usage: January 2018 to March 2023

AbstractFullPdf
Jan 2018210033
Feb 2018151028
Mar 2018138022
Apr 201886019
May 201865022
Jun 201828013
Jul 201859014
Aug 201875010
Sep 201844014
Oct 20182208
Nov 201833016
Dec 201834021
Jan 201950024
Feb 201968020
Mar 201932028
Apr 201917318
May 201923714
Jun 20196116
Jul 201922219
Aug 201922125
Oct 20192857
Nov 2019231211
Dec 20191894
Jan 20202779
Feb 2020601913
Mar 2020301216
May 202028710
Jun 202037313
Jul 20202005
Aug 202016621
Sep 20208375
Oct 20203048
Nov 202041117
Dec 20201795
Jan 2021734
Feb 20211894
Mar 202131187
Apr 20211642
May 20211015
Jun 20211033
Jul 20211326
Aug 20211041
Sep 20212169
Oct 202123322
Nov 202117615
Dec 20212652
Jan 20221820
Feb 2022721
Mar 20221133
Apr 2022601
May 202215314
Jun 20221114
Jul 20221701
Aug 2022303
Sep 20221108
Oct 20221202
Nov 202223010
Dec 2022703
Jan 2023161
Feb 20231414
Mar 2023701
Back to top
Posted January 26, 2018.
Download PDF

Supplementary Material

Email
Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in precision-medicine oriented early phase clinical trials
Pedro Torres-Ayuso, Sudhakar Sahoo, Melanie Galvin, Hui Sun Leong, Kristopher K Frese, Andrew Hughes, Richard Marais, Caroline Dive, Matthew G Krebs, John Brognard
bioRxiv 254342; doi: https://doi.org/10.1101/254342
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area